Mushtaq, Adeela <br/><br/>
Pomalidomide-Based Regimens for Treatment of Relapsed and Relapsed/Refractory Multiple Myeloma: Systematic Review and Meta-analysis of Phase 2 and 3 Clinical Trials.  [electronic resource] 

 -  Clinical lymphoma, myeloma & leukemia  07 2019 
 - 447-461 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Systematic Review 
<br/><br/><label>ISSN: </label>2152-2669 
<br/><br/><label>Standard No.: </label>10.1016/j.clml.2019.04.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Clinical Trials, Phase II as Topic<br/>Clinical Trials, Phase III as Topic<br/>Drug Resistance, Neoplasm<br/>Humans<br/>Multiple Myeloma--drug therapy<br/>Recurrence<br/>Retreatment<br/>Thalidomide--administration & dosage<br/>Treatment Outcome